ES2094093B1 - Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. - Google Patents
Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.Info
- Publication number
- ES2094093B1 ES2094093B1 ES9401999A ES9401999A ES2094093B1 ES 2094093 B1 ES2094093 B1 ES 2094093B1 ES 9401999 A ES9401999 A ES 9401999A ES 9401999 A ES9401999 A ES 9401999A ES 2094093 B1 ES2094093 B1 ES 2094093B1
- Authority
- ES
- Spain
- Prior art keywords
- magnesium
- aluminum
- basic carbonate
- liquid formulations
- pharmaceutical liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
FORMULACIONES FARMACEUTICAS LIQUIDAS MICROBIOLOGICAMENTE ESTABLES DE CARBONATO BASICO DE ALUMINIO Y MAGNESIO. LAS FORMULACIONES TIENEN COMO COMPONENTE PRINCIPAL EL CARBONATO BASICO DE ALUMINIO Y MAGNESIO, DE FORMULA AL2MG6(OH)14(CO3)2.4 H2O, CONOCIDO COMUNMENTE COMO ALMAGATO Y LLEVAN COMO AGENTES CONSERVANTES ANTIMICROBIANOS A COMPUESTOS DE ESTRUCTURA BIGUANIDINICA, EN CANTIDADES DE ENTRE 0,005 Y 0,05 POR CIENTO, JUNTO CON EXCIPIENTES O DILUYENTES FARMACEUTICAMENTE ACEPTABLES. ESTAS FORMULACIONES SE USAN POR VIA ORAL PARA EL TRATAMIENTO DE TRASTORNOS DE TRACTO GASTROINTESTINAL, ESPECIALMENTE LA HIPERACIDEZ GASTRICA.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9401999A ES2094093B1 (es) | 1994-09-22 | 1994-09-22 | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9401999A ES2094093B1 (es) | 1994-09-22 | 1994-09-22 | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2094093A1 ES2094093A1 (es) | 1997-01-01 |
ES2094093B1 true ES2094093B1 (es) | 1997-08-01 |
Family
ID=8287515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9401999A Expired - Fee Related ES2094093B1 (es) | 1994-09-22 | 1994-09-22 | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2094093B1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2153174B1 (es) * | 1971-09-23 | 1976-04-16 | Biotherax Lab | |
GB2030042A (en) * | 1978-09-21 | 1980-04-02 | Beecham Group Ltd | Antacid fondant |
FR2595249B1 (fr) * | 1986-03-10 | 1989-12-01 | Univ Victor Segalen Bordeaux 2 | Composition pharmaceutique consistant en une suspension de carbonate de calcium |
DE3612086A1 (de) * | 1986-04-10 | 1987-10-15 | Bayer Ag | Konservierte antacida-zubereitungen |
-
1994
- 1994-09-22 ES ES9401999A patent/ES2094093B1/es not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2094093A1 (es) | 1997-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996020734A3 (en) | Oral gastrointestinal x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants | |
BR0008039A (pt) | Combinações de formoterol e um sal de tiotrópio | |
FR2673538B1 (fr) | Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale. | |
HK1043048A1 (en) | Combinations of formoterol and mometasone furoate | |
CA2108455A1 (en) | Pharmaceutical compositions against gastric disorders | |
ATE290015T1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen | |
CA2468771A1 (en) | Pharmaceutical composition for use in ophthalmology and rhinology | |
NZ505073A (en) | Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases | |
FI950947A0 (fi) | Oraalisesti annettavat farmaseuttiset formulaatiot | |
CA2377174A1 (en) | Oral administration forms for administering a fixed tramadol and diclofenac combination | |
IL96995A0 (en) | Pharmaceutical compositions containing pimobendan and their preparation | |
WO1992018111A3 (en) | Pharmaceutical composition for the treatment of gastritis | |
HU9302970D0 (en) | Swallowable prepartions for the treatment of pains of superior gastrointestinal tracts | |
AU8687391A (en) | Lithium treatment | |
GR3024058T3 (en) | Pharmaceutical compositions containing 5-difluoromethoxy-2- (3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders | |
ES2094093B1 (es) | Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio. | |
BR9506956A (pt) | Composição farmacêutica antitussígena | |
MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
CA2330424A1 (en) | Improved method for eradication of helicobacter pylori | |
HK1012242A1 (en) | Topical composition containing penciclovir | |
RU99127647A (ru) | Средство для лечения сексуальных дисфункций у мужчин | |
CA2370501A1 (en) | Pharmaceutical composition for the therapy of lower urinary tract symptoms | |
MXPA04002099A (es) | Composiciones medicinales para neuropatia diabetica. | |
WO2002053118A3 (de) | Lichtschutzformulierungen mit einem gehalt an oberflächenaktiven saccharoseestern | |
AU4831279A (en) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19970101 Kind code of ref document: A1 Effective date: 19970101 |
|
PC2A | Transfer of patent | ||
FD2A | Announcement of lapse in spain |
Effective date: 20180806 |